These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6122856)

  • 1. Effect of beta-propiolactone in blood on routine haematological, biochemical, and serological investigations.
    Freeman R; Codd AA; Selkon JB
    Lancet; 1982 May; 1(8280):1048-9. PubMed ID: 6122856
    [No Abstract]   [Full Text] [Related]  

  • 2. Physical and chemical methods of inactivating Lassa virus.
    Lloyd G; Bowen ET; Slade JH
    Lancet; 1982 May; 1(8280):1046-8. PubMed ID: 6122855
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of beta-propiolactone on routine biochemical investigations.
    Dooley BJ; Harling NP; Lloyd G; van Heyningen C
    Med Lab Sci; 1985 Oct; 42(4):318-21. PubMed ID: 4079681
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of beta-propiolactone on some routine haematological tests.
    Atrah HI; Allardyce M; Davidson RJ
    Med Lab Sci; 1988 Oct; 45(4):308-11. PubMed ID: 3268715
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of combined treatment of serum containing hepatitis B virus with beta-propiolactone and ultraviolet irradiation.
    Stephan W; Berthold H; Prince AM
    Vox Sang; 1981 Sep; 41(3):134-8. PubMed ID: 7331286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of hepatitis A virus added to pooled human plasma by beta-propiolactone treatment and ultraviolet irradiation.
    Frösner GG; Stephan W; Dichtelmüller H
    Eur J Clin Microbiol; 1983 Aug; 2(4):355-7. PubMed ID: 6313360
    [No Abstract]   [Full Text] [Related]  

  • 7. [Beta-propiolactone for cold sterilization of heart valve transplants].
    Wutzler P; Sprössig M; Wenzel KP; Mücke H
    Z Exp Chir; 1975; 8(4):236-40. PubMed ID: 1053182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inactivation of hepatitis non-A, non-B virus in intravenous immunoglobulins by beta-propiolactone].
    Dichtelmüller H; Stephan W; Prince AM; Brotman B
    Beitr Infusionsther; 1988; 21():202-4. PubMed ID: 2462976
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cultivation of mycoplasma in fluid media sterilized with beta-propiolactone].
    Kiuntsel' V; Starost E; Meissner Kh
    Vestn Akad Med Nauk SSSR; 1976; (5):60-2. PubMed ID: 969882
    [No Abstract]   [Full Text] [Related]  

  • 10. [Beta-propiolactone as a sterilizing agent in the manufacture of intravenous immunoglobulin preparations].
    Stephan W; Dichtelmüller H
    Arzneimittelforschung; 1983; 33(9):1230-1. PubMed ID: 6416260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of hepatitis viruses and HIV in plasma and plasma derivatives by treatment with beta-propiolactone/UV irradiation.
    Stephan W
    Curr Stud Hematol Blood Transfus; 1989; (56):122-7. PubMed ID: 2642784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of beta-propiolactone in disinfection and sterilization. (According to foreign investigations)].
    BAZHINOV AG; KAMORSKII NM
    Zh Mikrobiol Epidemiol Immunobiol; 1960 Jul; 31():26-30. PubMed ID: 13688173
    [No Abstract]   [Full Text] [Related]  

  • 13. Virus safety of beta-propiolactone treated plasma preparations. Clinical experiences.
    Heinrich D; Sugg U; Brackmann HH; Stephan W; Lissner R
    Dev Biol Stand; 1987; 67():311-7. PubMed ID: 3649316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of the hepatitis safety of a beta-propiolactone/ultraviolet treated factor IX concentrate (PPSB).
    Heinrich D; Kotitschke R; Berthold H
    Thromb Res; 1982 Oct; 28(1):75-83. PubMed ID: 7157232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sterilization of instruments and materials with beta-propiolactone.
    ALLEN HF; MURPHY JT
    J Am Med Assoc; 1960 Apr; 172():1759-63. PubMed ID: 13792743
    [No Abstract]   [Full Text] [Related]  

  • 16. Sterilization of regenerated collagen sutures with beta-propiolactone.
    BALL EL; DORNBUSH AC; SIEGER GM; STIRN FE; VITUCCI JC; WEIDENHEIMER JF
    Appl Microbiol; 1961 Jul; 9(4):269-72. PubMed ID: 13686364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sterilization of culture media with beta-propiolactone].
    BAZHINOV AG; GARIN NS; KAMORSKII NM; KOMAROV VA
    Lab Delo; 1962 May; 8():46-9. PubMed ID: 13866080
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the problem of the use of beta-propiolactone in the sterilization of some labile biological preparations. (Preliminary communication)].
    GEFEN NE; RUDNEVA OA; BAZHINOV AG
    Zh Mikrobiol Epidemiol Immunobiol; 1962 Mar; 33():103-8. PubMed ID: 13897488
    [No Abstract]   [Full Text] [Related]  

  • 19. [Potency studies of sample rabies vaccine, inactivated by beta-propiolactone].
    Akan E
    Turk Hij Tecr Biyol Derg (1961); 1976; 36(2):172-88. PubMed ID: 1023462
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of combined beta-propiolactone/ultraviolet irradiation treatment on hepatitis B virus.
    Prince AM; Stephan W
    Lancet; 1980 Oct; 2(8200):917. PubMed ID: 6107566
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.